.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Medtronic
US Department of Justice
Covington
Fuji
Johnson and Johnson
Teva
Moodys
QuintilesIMS
Deloitte

Generated: September 22, 2017

DrugPatentWatch Database Preview

NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

What is the patent landscape for Normosol-r And Dextrose 5% In Plastic Container, and what generic Normosol-r And Dextrose 5% In Plastic Container alternatives are available?

Normosol-r And Dextrose 5% In Plastic Container is a drug marketed by Icu Medical Inc and is included in one NDA.

The generic ingredient in NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER is dextrose; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate. There are eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the dextrose; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate profile page.

Summary for Tradename: NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list106,440
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Icu Medical Inc
NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER
dextrose; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate
INJECTABLE;INJECTION017609-001Approved Prior to Jan 1, 1982RXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Healthtrust
UBS
Novartis
Express Scripts
Merck
Mallinckrodt
Moodys
US Department of Justice
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot